Copyright
©2014 Baishideng Publishing Group Inc.
World J Radiol. Oct 28, 2014; 6(10): 741-755
Published online Oct 28, 2014. doi: 10.4329/wjr.v6.i10.741
Published online Oct 28, 2014. doi: 10.4329/wjr.v6.i10.741
Figure 2 A 5-year-old male patient with relapsed T-cell lymphoblastic lymphoma.
Restaging PET at the time of relapse 1 year after initial therapy demonstrated an FDG-avid mediastinal mass (A, arrow). Repeat PET performed following 1 cycle of FLAG-Ida chemotherapy demonstrated no response to treatment and progression of disease to stage IV with extensive bone marrow involvement (B). PET: Positron emission tomography; FDG: 2-deoxy-2-(18F)fluoro-D-glucose.
- Citation: Freebody J, Wegner EA, Rossleigh MA. 2-deoxy-2-(18F)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology. World J Radiol 2014; 6(10): 741-755
- URL: https://www.wjgnet.com/1949-8470/full/v6/i10/741.htm
- DOI: https://dx.doi.org/10.4329/wjr.v6.i10.741